Internal Medicine, Pulmonary Disease · Springdale, AR
NPI
1063154219
Since 2022
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4600 Mercy Ln Ste 220
Springdale, AR, 72762
Phone (479) 347-3810
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
586 services
Medicare patients, 2024
289
Average age 74
Drug cost, 2024
$1.4M
2,811 prescriptions
Company payments, 2025
$2,115
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cassie Kaufman was code 99214 (office e&m - established), 141 times for 127 patients. In total Cassie Kaufman billed 586 services in 18 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 141 | 127 | $70.98 | $10K |
| 99215 Office E&M - Established | Office | 117 | 97 | $105.66 | $12K |
| 94618 Pulmonary Function Testing | Office | 79 | 75 | $19.63 | $1,551 |
| 99205 Office E&M - New | Office | 66 | 66 | $120.13 | $7,928 |
| 99213 Office E&M - Established | Office | 48 | 45 | $47.60 | $2,285 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 44 | 42 | $10.22 | $450 |
| 99204 Office E&M - New | Office | 38 | 38 | $91.24 | $3,467 |
| G0009 Administration of pneumococcal vaccine | Office | 13 | 13 | $29.23 | $380 |
| 90677 Vaccine Product | Office | 13 | 13 | $292.08 | $3,797 |
By year: 2023 $30K for 382 services; 2024 $43K for 586 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cassie Kaufman prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 491 prescriptions and refills. In total Cassie Kaufman wrote 2,811 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 491 | 588 | 121 | $371K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 276 | 323 | 116 | $6,351 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 265 | 305 | 89 | $189K |
| Prednisone Generic | 164 | 180 | 115 | $459 |
| Famotidine Generic | 145 | 238 | 42 | $2,347 |
| Pantoprazole Sodium Generic | 139 | 278 | 46 | $1,514 |
| Azithromycin Generic | 114 | 210 | 57 | $1,746 |
| Doxycycline Hyclate Generic | 87 | 87 | 78 | $692 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 63 | 66 | 25 | $31K |
| Nucala Mepolizumab | 62 | 62 | Under 11 | $437K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 61 | 69 | 21 | $32K |
| Montelukast Sodium Generic | 60 | 174 | 28 | $515 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 59 | 69 | 19 | $4,422 |
| Symbicort Budesonide/Formoterol Fumarate | 52 | 65 | 22 | $13K |
| Ventolin Hfa Albuterol Sulfate | 51 | 53 | 17 | $3,032 |
Brand drugs: 1,524 claims; generic drugs: 1,287 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cassie Kaufman $2,115 ($2,115 in general payments such as food, travel and fees) from 17 companies. The largest payer was GlaxoSmithKline, LLC. with $450.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 20 | $450 |
| Viatris Specialty LLC | 13 | $275 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $236 |
| Grifols USA, LLC | 7 | $187 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $166 |
| Insmed, Inc. INSM | 7 | $136 |
| Baxter Healthcare BAX | 5 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $107 |
| United Therapeutics Corporation UTHR | 4 | $90.94 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $75.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.